T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? (Q82323349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

M Heron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A M E Claessen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J C Grutters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J M M van den Bosch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

17 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

256-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders

15 January 2020

cites work

1 reference

12 December 2020

T cell subset-specific susceptibility to aging.

1 reference

12 December 2020

Immune mechanisms in interstitial lung diseases.

1 reference

12 December 2020

Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis

1 reference

12 December 2020

Down-regulation of CD28 expression by TNF-alpha

1 reference

12 December 2020

CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity

1 reference

12 December 2020

Hypersensitivity pneumonitis: current concepts.

1 reference

12 December 2020

Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases

1 reference

12 December 2020

T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection

1 reference

12 December 2020

Alveolitis: the key to the interstitial lung disorders

1 reference

12 December 2020

Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract

1 reference

12 December 2020

Sarcoidosis: epidemiology and prognosis. A 15-year European study

1 reference

12 December 2020

VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation.

1 reference

12 December 2020

The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival

1 reference

12 December 2020

T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1

1 reference

12 December 2020

T cell activation via Leu-23 (CD69)

1 reference

12 December 2020

T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients

1 reference

12 December 2020

1 reference

12 December 2020

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

12 December 2020

Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence

1 reference

12 December 2020

The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum

1 reference

12 December 2020

Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis.

1 reference

12 December 2020

Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases

1 reference

12 December 2020

Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis

1 reference

12 December 2020

CD69 is an immunoregulatory molecule induced following activation

1 reference

12 December 2020

CD4+CD28-T cells are expanded in sarcoidosis

1 reference

12 December 2020

Corticosteroid treatment in sarcoidosis

1 reference

12 December 2020

Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis

1 reference

12 December 2020

Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.

1 reference

12 December 2020

10.1111/J.1365-2249.2009.04076.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20030671%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference